193 related articles for article (PubMed ID: 7640349)
21. Long-term effects of nicotinamide-induced inhibition of poly(adenosine diphosphate-ribose) polymerase activity in rat pancreatic islets exposed to interleukin-1 beta.
Reddy S; Salari-Lak N; Sandler S
Endocrinology; 1995 May; 136(5):1907-12. PubMed ID: 7720637
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-1 beta-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase.
Welsh N; Eizirik DL; Bendtzen K; Sandler S
Endocrinology; 1991 Dec; 129(6):3167-73. PubMed ID: 1720090
[TBL] [Abstract][Full Text] [Related]
23. Rat pancreatic islet and RINm5F cell responses to epiandrosterone, dehydroepiandrosterone and interleukin-1 beta.
Laychock SG
Biochem Pharmacol; 1998 May; 55(9):1453-64. PubMed ID: 10076538
[TBL] [Abstract][Full Text] [Related]
24. Functional characteristics of rat pancreatic islets maintained in culture after exposure to human interleukin 1.
Eizirik DL; Strandell E; Bendtzen K; Sandler S
Diabetes; 1988 Jul; 37(7):916-9. PubMed ID: 3290009
[TBL] [Abstract][Full Text] [Related]
25. Ciliary neurotrophic factor potentiates the beta-cell inhibitory effect of IL-1beta in rat pancreatic islets associated with increased nitric oxide synthesis and increased expression of inducible nitric oxide synthase.
Wadt KA; Larsen CM; Andersen HU; Nielsen K; Karlsen AE; Mandrup-Poulsen T
Diabetes; 1998 Oct; 47(10):1602-8. PubMed ID: 9753298
[TBL] [Abstract][Full Text] [Related]
26. Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide.
Corbett JA; Wang JL; Sweetland MA; Lancaster JR; McDaniel ML
J Clin Invest; 1992 Dec; 90(6):2384-91. PubMed ID: 1334975
[TBL] [Abstract][Full Text] [Related]
27. Studies on the mechanisms causing inhibition of insulin secretion in rat pancreatic islets exposed to human interleukin-1 beta indicate a perturbation in the mitochondrial function.
Sandler S; Bendtzen K; Borg LA; Eizirik DL; Strandell E; Welsh N
Endocrinology; 1989 Mar; 124(3):1492-501. PubMed ID: 2521822
[TBL] [Abstract][Full Text] [Related]
28. Reversibility of interleukin-1 beta-induced islet destruction and dysfunction by the inhibition of nitric oxide synthase.
Corbett JA; McDaniel ML
Biochem J; 1994 May; 299 ( Pt 3)(Pt 3):719-24. PubMed ID: 7514870
[TBL] [Abstract][Full Text] [Related]
29. Effects of 1,25-dihydroxyvitamin D3 and the analogues MC903 and KH1060 on interleukin-1 beta-induced inhibition of rat pancreatic islet beta-cell function in vitro.
Sandler S; Buschard K; Bendtzen K
Immunol Lett; 1994 Jun; 41(1):73-7. PubMed ID: 7959906
[TBL] [Abstract][Full Text] [Related]
30. Intraislet release of interleukin 1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide synthase.
Corbett JA; McDaniel ML
J Exp Med; 1995 Feb; 181(2):559-68. PubMed ID: 7530759
[TBL] [Abstract][Full Text] [Related]
31. Nicotinamide prevents interleukin-1 effects on accumulated insulin release and nitric oxide production in rat islets of Langerhans.
Andersen HU; Jørgensen KH; Egeberg J; Mandrup-Poulsen T; Nerup J
Diabetes; 1994 Jun; 43(6):770-7. PubMed ID: 8194662
[TBL] [Abstract][Full Text] [Related]
32. Strain-dependent differences in sensitivity of rat beta-cells to interleukin 1 beta in vitro and in vivo: association with islet nitric oxide synthesis.
Reimers JI; Andersen HU; Mauricio D; Pociot F; Karlsen AE; Petersen JS; Mandrup-Poulsen T; Nerup J
Diabetes; 1996 Jun; 45(6):771-8. PubMed ID: 8635652
[TBL] [Abstract][Full Text] [Related]
33. Suppressive effects of a selective inducible nitric oxide synthase (iNOS) inhibitor on pancreatic beta-cell dysfunction.
Kato Y; Miura Y; Yamamoto N; Ozaki N; Oiso Y
Diabetologia; 2003 Sep; 46(9):1228-33. PubMed ID: 12898012
[TBL] [Abstract][Full Text] [Related]
34. Potential role of resident islet macrophage activation in the initiation of autoimmune diabetes.
Arnush M; Scarim AL; Heitmeier MR; Kelly CB; Corbett JA
J Immunol; 1998 Mar; 160(6):2684-91. PubMed ID: 9510167
[TBL] [Abstract][Full Text] [Related]
35. Copper addition prevents the inhibitory effects of interleukin 1-beta on rat pancreatic islets.
Vinci C; Caltabiano V; Santoro AM; Rabuazzo AM; Buscema M; Purrello R; Rizzarelli E; Vigneri R; Purrello F
Diabetologia; 1995 Jan; 38(1):39-45. PubMed ID: 7744228
[TBL] [Abstract][Full Text] [Related]
36. Tumor necrosis factor-alpha and interferon-gamma inhibit insulin secretion and cause DNA damage in unweaned-rat islets. Extent of nitric oxide involvement.
Dunger A; Cunningham JM; Delaney CA; Lowe JE; Green MH; Bone AJ; Green IC
Diabetes; 1996 Feb; 45(2):183-9. PubMed ID: 8549863
[TBL] [Abstract][Full Text] [Related]
37. Differential sensitivity to beta-cell secretagogues in cultured rat pancreatic islets exposed to human interleukin-1 beta.
Eizirik DL; Sandler S; Hallberg A; Bendtzen K; Sener A; Malaisse WJ
Endocrinology; 1989 Aug; 125(2):752-9. PubMed ID: 2666106
[TBL] [Abstract][Full Text] [Related]
38. Liposomal delivery of antioxidant enzymes protects against hydrogen peroxide- but not interleukin-1 beta-induced inhibition of glucose metabolism in rat pancreatic islets.
Welsh N; Margulis B; Bendtzen K; Sandler S
J Endocrinol; 1994 Oct; 143(1):151-6. PubMed ID: 7964313
[TBL] [Abstract][Full Text] [Related]
39. A 1-hour pulse with IL-1 beta induces formation of nitric oxide and inhibits insulin secretion by rat islets of Langerhans: evidence for a tyrosine kinase signaling mechanism.
Corbett JA; Sweetland MA; Lancaster JR; McDaniel ML
FASEB J; 1993 Feb; 7(2):369-74. PubMed ID: 8440413
[TBL] [Abstract][Full Text] [Related]
40. Nitric oxide mediates IL-1 beta-induced islet dysfunction and destruction: prevention by dexamethasone.
Corbett JA; Wang JL; Misko TP; Zhao W; Hickey WF; McDaniel ML
Autoimmunity; 1993; 15(2):145-53. PubMed ID: 7692996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
